Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,570 | 109,060 | 106,972 | 127,741 | 149,252 |
| Marketable Securities | 46,830 | 29,290 | 35,502 | 45,896 | 34,409 |
| Receivables | 58,350 | 47,940 | 47,341 | 66,633 | 47,321 |
| Inventories | 47,480 | 55,420 | 60,174 | 48,402 | 28,192 |
| Other current assets | 21,180 | 21,630 | 24,228 | 13,045 | 2,805 |
| TOTAL | $232,410 | $263,340 | $274,217 | $301,717 | $261,979 |
| Non-Current Assets | |||||
| PPE Net | 39,550 | 41,480 | 41,027 | 36,394 | 25,495 |
| Investments And Advances | 25,510 | 17,290 | 11,134 | 7,255 | 13,626 |
| Other Non-Current Assets | 62,670 | 68,400 | 50,670 | 28,486 | 11,440 |
| TOTAL | $127,730 | $127,170 | $102,831 | $72,135 | $50,561 |
| Total Assets | $360,150 | $390,530 | $377,048 | $373,852 | $312,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,250 | 5,190 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 19,640 | 26,810 | 12,472 | 18,692 | 10,807 |
| Accrued Expenses | 40,180 | 32,040 | 42,147 | 23,872 | 16,657 |
| Other current liabilities | 12,440 | 14,440 | 15,609 | 5,563 | 4,264 |
| TOTAL | $75,520 | $78,500 | $74,315 | $51,127 | $33,415 |
| Non-Current Liabilities | |||||
| Long Term Debt | 290 | 4,190 | 0 | 0 | 0 |
| TOTAL | $290 | $4,190 | $N/A | $N/A | $N/A |
| Total Liabilities | $75,810 | $82,690 | $74,315 | $51,127 | $33,415 |
| Shareholders' Equity | |||||
| Common Shares | 3,950 | 3,880 | 3,817 | 3,777 | 3,655 |
| Retained earnings | 63,610 | 31,040 | 46,256 | 67,376 | 45,222 |
| Other shareholders' equity | -3,670 | -3,370 | -4,615 | -1,546 | -558 |
| TOTAL | $284,340 | $307,840 | $302,733 | $322,725 | $279,125 |
| Total Liabilities And Equity | $360,150 | $390,530 | $377,048 | $373,852 | $312,540 |